Koligo Therapeutics, Inc.
Biotechnology company · New Albany, Indiana, United States
Koligo Therapeutics, Inc. is a biotechnology company headquartered in New Albany, Indiana, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $1.6 million sold in a notice filed in 2020.
Koligo Therapeutics at a glance
What does Koligo Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $1.6 million sold (2020).
Frequently asked questions about Koligo Therapeutics
Where is Koligo Therapeutics headquartered?
Koligo Therapeutics, Inc. is headquartered in New Albany, Indiana, United States.
What does Koligo Therapeutics do?
Koligo Therapeutics, Inc. is a biotechnology company.
When was Koligo Therapeutics founded?
The earliest incorporation on record for Koligo Therapeutics, Inc. is in 2016, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences